Trials / Recruiting
RecruitingNCT06907017
CorWave LVAS FIH Study
First In Human Clinical Study of the CorWave Left Ventricular Assist System for the Treatment of Patients With Advanced Heart Failure
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- CorWave · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The study is a prospective, multi-center, non-randomized trial to evaluate the safety and effectiveness of the CorWave LVAS for the treatment of advanced heart failure patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | LVAS | Implantation and use of the CorWave LVAS to evaluate the safety and effectiveness of the CorWave LVAD to treat advanced left ventricular heart failure. |
Timeline
- Start date
- 2025-05-06
- Primary completion
- 2026-05-01
- Completion
- 2028-05-01
- First posted
- 2025-04-02
- Last updated
- 2026-02-09
Locations
2 sites across 1 country: Australia
Source: ClinicalTrials.gov record NCT06907017. Inclusion in this directory is not an endorsement.